{"id":"https://openalex.org/W4282946261","doi":"https://doi.org/10.1080/13696998.2022.2087408","title":"Budget impact analysis of belumosudil for chronic graft-versus-host disease treatment in the United States","display_name":"Budget impact analysis of belumosudil for chronic graft-versus-host disease treatment in the United States","publication_year":2022,"publication_date":"2022-06-08","ids":{"openalex":"https://openalex.org/W4282946261","doi":"https://doi.org/10.1080/13696998.2022.2087408","pmid":"https://pubmed.ncbi.nlm.nih.gov/35674411"},"language":"en","primary_location":{"id":"doi:10.1080/13696998.2022.2087408","doi":"https://doi.org/10.1080/13696998.2022.2087408","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13696998.2022.2087408","pdf_url":null,"source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1080/13696998.2022.2087408","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026503525","display_name":"Carlos R. Bachier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101244","display_name":"Methodist Healthcare","ror":"https://ror.org/016d8zs37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210101244"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Carlos R. Bachier","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX, USA","institution_ids":["https://openalex.org/I4210101244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112578607","display_name":"Jeffrey Rolf Skaar","orcid":"https://orcid.org/0009-0004-0069-6033","observed_orcids":["https://orcid.org/0009-0004-0069-6033"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey R. Skaar","raw_affiliation_strings":["Evidence Strategy, Trinity Life Sciences, Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidence Strategy, Trinity Life Sciences, Waltham, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012428116","display_name":"Sumudu Dehipawala","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sumudu Dehipawala","raw_affiliation_strings":["Evidence Strategy, Trinity Life Sciences, Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidence Strategy, Trinity Life Sciences, Waltham, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042107754","display_name":"Benjamin Miao","orcid":"https://orcid.org/0000-0002-2550-5027","observed_orcids":["https://orcid.org/0000-0002-2550-5027"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Miao","raw_affiliation_strings":["Evidence Strategy, Trinity Life Sciences, Waltham, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-2550-5027","affiliations":[{"raw_affiliation_string":"Evidence Strategy, Trinity Life Sciences, Waltham, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066521956","display_name":"Jonathan Ieyoub","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155476","display_name":"Kadmon Corporation (United States)","ror":"https://ror.org/0391bdf37","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804","https://openalex.org/I4387155476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Ieyoub","raw_affiliation_strings":["A Sanofi Company, Kadmon Corporation, LLC, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A Sanofi Company, Kadmon Corporation, LLC, New York, NY, USA","institution_ids":["https://openalex.org/I4387155476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024900141","display_name":"Haya Taitel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155476","display_name":"Kadmon Corporation (United States)","ror":"https://ror.org/0391bdf37","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804","https://openalex.org/I4387155476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haya Taitel","raw_affiliation_strings":["A Sanofi Company, Kadmon Corporation, LLC, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A Sanofi Company, Kadmon Corporation, LLC, New York, NY, USA","institution_ids":["https://openalex.org/I4387155476"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5026503525"],"corresponding_institution_ids":["https://openalex.org/I4210101244"],"apc_list":null,"apc_paid":null,"fwci":0.9264,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.80193199,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"25","issue":"1","first_page":"857","last_page":"863"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7788000106811523,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7788000106811523,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.155799999833107,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.016499999910593033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/belumosudil","display_name":"belumosudil","score":0.9850000143051147},{"id":"https://openalex.org/keywords/chronic-graft-versus-host-disease","display_name":"chronic graft-versus-host disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/budget-impact","display_name":"budget impact","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.6639999747276306},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.6579999923706055},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9169999957084656},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7929999828338623},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cost-of-care","display_name":"cost of care","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7959009408950806},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.492591917514801},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.47367388010025024},{"id":"https://openalex.org/C28761237","wikidata":"https://www.wikidata.org/wiki/Q7805321","display_name":"Time horizon","level":2,"score":0.4727148711681366},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.42795321345329285},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.4269316494464874},{"id":"https://openalex.org/C188897","wikidata":"https://www.wikidata.org/wiki/Q5333508","display_name":"Economic impact analysis","level":2,"score":0.41963958740234375},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.34328174591064453},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.2830066978931427},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.2507660388946533},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.1558389961719513},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.12949052453041077},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.11744385957717896},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002017","descriptor_name":"Budgets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003695","descriptor_name":"Delivery of Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017046","descriptor_name":"Cost Savings","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/13696998.2022.2087408","doi":"https://doi.org/10.1080/13696998.2022.2087408","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13696998.2022.2087408","pdf_url":null,"source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},{"id":"pmid:35674411","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35674411","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medical economics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/13696998.2022.2087408","doi":"https://doi.org/10.1080/13696998.2022.2087408","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13696998.2022.2087408","pdf_url":null,"source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W2010965954","https://openalex.org/W2031549987","https://openalex.org/W2111276737","https://openalex.org/W2139063774","https://openalex.org/W2139349555","https://openalex.org/W2379365975","https://openalex.org/W2618073389","https://openalex.org/W2754850852","https://openalex.org/W2934805194","https://openalex.org/W2980625838","https://openalex.org/W3021734669","https://openalex.org/W3095621154","https://openalex.org/W3097188868","https://openalex.org/W3114437587","https://openalex.org/W3153469960","https://openalex.org/W4247737273"],"related_works":["https://openalex.org/W4413787334","https://openalex.org/W4415669710","https://openalex.org/W7124231799","https://openalex.org/W4415243763","https://openalex.org/W7215881760","https://openalex.org/W7127416386","https://openalex.org/W7124899445","https://openalex.org/W7134199097","https://openalex.org/W4409059593","https://openalex.org/W4417016755"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"assess":[2],"the":[3,8,54,70,85,128,220,225,236,254],"impact":[4,32,37,126],"of":[5,10,26,58,109,157,239,256],"belumosudil":[6,141,257,275],"on":[7,140,224],"cost":[9,155,266],"care":[11],"in":[12,46,146,176],"chronic":[13],"graft-versus-host":[14],"disease":[15],"(cGVHD)":[16],"patients":[17,63],"who":[18],"have":[19],"failed":[20],"at":[21],"least":[22],"two":[23,83],"prior":[24],"lines":[25],"systemic":[27],"therapy":[28],"using":[29],"a":[30,40,90,270,277],"budget":[31,36,125],"model.":[33],"METHODS:":[34],"A":[35],"model":[38,52,76,79,104,221,250],"with":[39,69,98,264,272],"5-year":[41],"time":[42],"horizon":[43],"was":[44,134],"constructed":[45],"Microsoft":[47],"Excel.":[48],"The":[49,78,122,249],"base":[50],"case":[51],"uses":[53],"US":[55,87,92,129,278],"prevalence":[56],"rate":[57],"3":[59,147],"L/4L":[60],"+":[61,152],"cGVHD":[62,110,137,260],"from":[64,168,180,219,235,276],"literature":[65],"and":[66,89,117,131,149,159,162,170,184,190,195,197,201,207,229,243,246],"secondary":[67],"sources,":[68],"potential":[71,123],"for":[72,82,127,136,188,205],"user-defined":[73],"inputs,":[74],"including":[75],"perspectives.":[77],"includes":[80],"data":[81,227],"perspectives:":[84],"national":[86,130,169,189,206],"population":[88],"hypothetical":[91],"private":[93],"payer":[94,132,171,191,208,279],"health":[95],"insurance":[96],"plan":[97],"10":[99],"million":[100],"(Mil)":[101],"members.":[102],"Additional":[103],"inputs":[105,228],"include":[106],"market":[107,241],"share":[108],"treatments,":[111,240],"their":[112],"associated":[113,263],"adverse":[114],"event":[115],"rates,":[116],"healthcare":[118],"resource":[119],"utilization.":[120],"RESULTS:":[121],"annual":[124],"plans":[133],"evaluated":[135],"patients.":[138],"Based":[139],"utilization":[142],"increasing":[143],"to":[144,258],"55%":[145],"L":[148,151],"4":[150],"by":[153],"2026,":[154],"savings":[156,175,267],"\u223c5.5%":[158],"6.7%":[160],"($128.8":[161],"$4.9":[163],"Mil":[164,186,203],"USD)":[165],"were":[166,178,222],"observed":[167],"perspectives,":[172],"respectively.":[173],"Cost":[174],"2026":[177],"derived":[179],"fewer":[181],"AEs":[182],"($108.4":[183],"$3.9":[185],"USD,":[187,204],"perspectives;":[192,209],"e.g.":[193,210],"neutropenia,":[194],"thrombocytopenia)":[196],"reduced":[198],"HCRU":[199],"($65.1":[200],"$2.3":[202],"emergency":[211],"room":[212],"visits,":[213],"ICU":[214],"stays,":[215],"etc.).":[216],"LIMITATIONS:":[217],"Results":[218],"dependent":[223],"available":[226],"assumptions.":[230],"Real-world":[231],"values":[232],"may":[233],"differ":[234],"assumed":[237],"performance":[238],"growth,":[242],"treatment":[244],"dosing":[245],"duration.":[247],"CONCLUSION:":[248],"results":[251],"suggest":[252],"that":[253],"introduction":[255],"treat":[259],"would":[261],"be":[262],"substantial":[265],"when":[268],"evaluating":[269],"scenario":[271],"versus":[273],"without":[274],"perspective.":[280]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-16T00:00:00"}